Robert E. Fricke

475 total citations
16 papers, 287 citations indexed

About

Robert E. Fricke is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Pharmacology. According to data from OpenAlex, Robert E. Fricke has authored 16 papers receiving a total of 287 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 5 papers in Epidemiology and 5 papers in Pharmacology. Recurrent topics in Robert E. Fricke's work include Pharmacogenetics and Drug Metabolism (5 papers), Prostate Cancer Treatment and Research (4 papers) and Radiopharmaceutical Chemistry and Applications (3 papers). Robert E. Fricke is often cited by papers focused on Pharmacogenetics and Drug Metabolism (5 papers), Prostate Cancer Treatment and Research (4 papers) and Radiopharmaceutical Chemistry and Applications (3 papers). Robert E. Fricke collaborates with scholars based in Germany, United States and Finland. Robert E. Fricke's co-authors include Olaf Prien, Christian Zurth, Mikko Koskinen, Hille Gieschen, Karsten Denner, Timo Korjamo, Gary Wilkinson, Michaela Bairlein, David G. Decker and Jonathan Moss and has published in prestigious journals such as Journal of Clinical Oncology, Radiology and American Journal of Obstetrics and Gynecology.

In The Last Decade

Robert E. Fricke

16 papers receiving 279 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert E. Fricke Germany 7 128 90 60 56 51 16 287
Martha Gonzalez United States 11 197 1.5× 70 0.8× 87 1.4× 50 0.9× 137 2.7× 21 408
T Böttger Germany 8 72 0.6× 106 1.2× 19 0.3× 82 1.5× 58 1.1× 30 353
Alla Shapiro United States 7 150 1.2× 53 0.6× 117 1.9× 11 0.2× 83 1.6× 10 388
Bas Peters Netherlands 15 149 1.2× 167 1.9× 18 0.3× 57 1.0× 94 1.8× 38 464
A.P.R. Blok Netherlands 11 42 0.3× 62 0.7× 33 0.6× 119 2.1× 59 1.2× 15 384
Robert J. Irwin United States 16 181 1.4× 66 0.7× 42 0.7× 12 0.2× 130 2.5× 26 502
Amy Sion United States 5 98 0.8× 115 1.3× 21 0.3× 44 0.8× 33 0.6× 8 238
M Pirrelli Italy 12 106 0.8× 173 1.9× 33 0.6× 37 0.7× 91 1.8× 34 445
Joanna Leadbetter Australia 7 121 0.9× 105 1.2× 97 1.6× 36 0.6× 93 1.8× 14 438
Kim A. Johnson United States 10 112 0.9× 157 1.7× 13 0.2× 64 1.1× 118 2.3× 16 363

Countries citing papers authored by Robert E. Fricke

Since Specialization
Citations

This map shows the geographic impact of Robert E. Fricke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert E. Fricke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert E. Fricke more than expected).

Fields of papers citing papers by Robert E. Fricke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert E. Fricke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert E. Fricke. The network helps show where Robert E. Fricke may publish in the future.

Co-authorship network of co-authors of Robert E. Fricke

This figure shows the co-authorship network connecting the top 25 collaborators of Robert E. Fricke. A scholar is included among the top collaborators of Robert E. Fricke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert E. Fricke. Robert E. Fricke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Gadaleta, Domenico, et al.. (2025). Predicting Liver-Related In Vitro Endpoints with Machine Learning to Support Early Detection of Drug-Induced Liver Injury. Chemical Research in Toxicology. 38(4). 656–671. 1 indexed citations
2.
Schulz, Simone I., Dieter Lang, Gabriele Schmuck, et al.. (2023). In vivo Metabolism of Nifurtimox and the Drug-Drug Interaction Potential Including its Major Metabolites. Current Drug Metabolism. 24(8). 599–610. 1 indexed citations
3.
Kanefendt, Friederike, et al.. (2023). Pharmacokinetics of asundexian with combined CYP3A and P‐gp inhibitors and an inducer: Target in vitro and in vivo studies. British Journal of Clinical Pharmacology. 90(4). 1036–1049. 5 indexed citations
4.
Heinig, Roland, et al.. (2022). Results From Drug–Drug Interaction Studies In Vitro and In Vivo Investigating the Inhibitory Effect of Finerenone on the Drug Transporters BCRP, OATP1B1, and OATP1B3. European Journal of Drug Metabolism and Pharmacokinetics. 47(6). 803–815. 9 indexed citations
5.
Wiesinger, Herbert, Stefan Klein, Antje Rottmann, et al.. (2020). The Effects of Weak and Strong CYP3A Induction by Rifampicin on the Pharmacokinetics of Five Progestins and Ethinylestradiol Compared to Midazolam. Clinical Pharmacology & Therapeutics. 108(4). 798–807. 22 indexed citations
6.
Zurth, Christian, Mikko Koskinen, Robert E. Fricke, et al.. (2019). Drug–Drug Interaction Potential of Darolutamide: In Vitro and Clinical Studies. European Journal of Drug Metabolism and Pharmacokinetics. 44(6). 747–759. 71 indexed citations
7.
8.
Zurth, Christian, Karim Fizazi, Robert E. Fricke, et al.. (2019). Assessing the clinical relevance of drug-drug interactions (DDI) with darolutamide (DARO). Annals of Oncology. 30. v350–v350. 3 indexed citations
9.
Zurth, Christian, Karsten Denner, Timo Korjamo, et al.. (2019). Drug-drug interaction (DDI) of darolutamide with cytochrome P450 (CYP) and P-glycoprotein (P-gp) substrates: Results from clinical and in vitro studies.. Journal of Clinical Oncology. 37(7_suppl). 297–297. 9 indexed citations
10.
Di, Li, Robert Chambers, Sean Eckley, et al.. (2017). Industry Perspective on Contemporary Protein-Binding Methodologies: Considerations for Regulatory Drug-Drug Interaction and Related Guidelines on Highly Bound Drugs. Journal of Pharmaceutical Sciences. 106(12). 3442–3452. 70 indexed citations
11.
Fricke, Robert E. & David G. Decker. (1957). TREATMENT AND PROGNOSIS IN ELDERLY PATIENTS WITH CANCER OF THE CERVIX†. Journal of the American Geriatrics Society. 5(2). 183–186. 2 indexed citations
12.
Decker, David G., et al.. (1957). Carcinoma of the Cervical Stump. American Journal of Obstetrics and Gynecology. 73(5). 974–984. 15 indexed citations
13.
Fricke, Robert E., et al.. (1956). RESULTS OF TREATMENT OF PRIMARY ADENO‐ACANTHOMA OF THE UTERINE CERVIX, INCLUDING 2 CASES OF ADENOCARCINOMA ASSOCIATED WITH SQUAMOUS‐CELL CARCINOMA “IN SITU“†. Journal of the American Geriatrics Society. 4(2). 113–116. 2 indexed citations
14.
Fricke, Robert E.. (1954). TWO UNUSUAL CASES OF PELVIC CANCER*. Journal of the American Geriatrics Society. 2(5). 324–327. 5 indexed citations
15.
Fricke, Robert E., et al.. (1954). Treatment of Rare Lesions of the Uterus and Vagina. Radiology. 63(3). 353–360. 5 indexed citations
16.
Fricke, Robert E., et al.. (1951). Radium and Surgical Treatment of Retinoblastoma. Surgical Clinics of North America. 31(4). 1147–1155. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Martha Gonzalez Breakdown of academic impact, for papers by T Böttger Breakdown of academic impact, for papers by Alla Shapiro Breakdown of academic impact, for papers by Bas Peters Breakdown of academic impact, for papers by A.P.R. Blok Breakdown of academic impact, for papers by Robert J. Irwin Breakdown of academic impact, for papers by Amy Sion Breakdown of academic impact, for papers by M Pirrelli Breakdown of academic impact, for papers by Joanna Leadbetter Breakdown of academic impact, for papers by Kim A. Johnson
Rankless by CCL
2026